Q2 2020
Released Aug 6, 2020, before the open
10-Q filed Aug 6, 2020, 37 days after period end · 0001104659-20-091145
Q2 2020 · 10-Q
Revenue—
Net Income-$6.37M-$6.37M N/M vs Q2 2019N/M vs Q1 2020
EPS Diluted-$0.13-$0.13 N/M vs Q2 2019N/M vs Q1 2020
Operating Income-$4,222,519N/M
Operating Cash Flowderived-$4,079,248N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 |
| Net Income | -$6.37M | -$3.43M | -$3.26M | -$6.09M |
| EPS Diluted | -$0.13 | -$0.14 | -$0.15 | -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR